$3.22
0.092.88%
Last update: Nov 9, 4:00 PM
Whitehawk Therapeutics Inc
WHWKNASDAQ
The average analyst price target for Whitehawk Therapeutics is $8.60, 167.1% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $7 to $10. The latest change came on Oct 1, 2026, when Stifel initiated coverage of Whitehawk Therapeutics with a Buy rating and a $9 price target.
Price Target Range — 4 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
